The growing impact of click chemistry on drug discovery
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (24) , 1128-1137
- https://doi.org/10.1016/s1359-6446(03)02933-7
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cell Surface Labeling of Escherichia coli via Copper(I)-Catalyzed [3+2] CycloadditionJournal of the American Chemical Society, 2003
- A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click ChemistryJournal of the American Chemical Society, 2003
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Synthesis and Evaluation of Transition-State Analogue Inhibitors of α-1,3-Fucosyltransferase This work was supported by the NIH and the Skaggs Institute. M.L.M. acknowledges fellowships from UNCF⋅Merck Science Initiative and Skaggs Predoctoral Fellows Program.Angewandte Chemie International Edition in English, 2002
- A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal AlkynesAngewandte Chemie International Edition in English, 2002
- Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and IminesPublished by Wiley ,2000
- Hydrophobic Effects in 1,3-Dipolar Cycloaddition of C,N-Diphenylnitrone with Dibutyl fumarate in Aqueous SolutionsJournal of Chemical Research, 1999
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition in English, 1998
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996
- Catalytic Asymmetric DihydroxylationChemical Reviews, 1994